Treatment of Idiopathic Membranous Nephropathy With the Herb Astragalus membranaceus

American Journal of Kidney Diseases

Volumn 50, Issue 6, 2007, Pages 1028-1032

  Ahmed, Mohammed S ^a   Hou, Susan H ^a   Battaglia, M Carol ^a   Picken, Maria M ^a   Leehey, David J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Astragalus membranaceus; idiopathic membranous nephropathy; Proteinuria

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; CHINESE DRUG; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HERBACEOUS AGENT; LISINOPRIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SHEN YAN SIWEI PIAN; UNCLASSIFIED DRUG; VALSARTAN;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; ASTRAGALUS MEMBRANACEUS; CASE REPORT; CHINESE MEDICINE; DISEASE COURSE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; EDEMA; FEMALE; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; HYPOALBUMINEMIA; IDIOPATHIC DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PROTEINURIA; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

AGED; ASTRAGALUS MEMBRANACEUS; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY GLOMERULUS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 36249005470     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.07.032     Document Type: Article

References (15)

1. Hogan S.L., Muller K.E., Jennette J.C., and Falk R.J. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 25 (1995) 862-875
2. Honkanen E., Tornroth T., and Gronhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 7 suppl 1 (1992) S35-S41
3. Falk R.J., Jennette J.C., and Nachman P.H. Primary glomerular disease. In: Brenner B.M. (Ed). Brenner & Rector's The Kidney. ed 7 (2004), Saunders, Philadelphia, PA 1293-1380
4. du Buf-Vereijken P.W., Branten A.J., and Wetzels J.F. Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy. Am J Kidney Dis 46 (2005) 1012-1029
5. Peng A., Gu Y., and Lin S.Y. Herbal treatment for renal diseases. Ann Acad Med Singapore 34 (2005) 44-51
6. Cheng K.T., Tsay H.S., Chen C.F., and Chou T.W. Determination of the components in a Chinese prescription, yu-ping-feng san, by RAPD analysis. Planta Med 64 (1998) 563-565
7. Wang Y.P., Li X.Y., Song C.Q., and Hu Z.B. Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 23 (2002) 263-266
8. Zhao Z.X. Effects of Astragalus membranaceus and Tripterygium hypglancum on natural killer cell activity of peripheral blood mononuclear cells in systemic lupus erythematosus. Zhongguo Zhong Xi Yi Jie He Za Zhi 12 (1992) 669-671
9. Shi J.F., Zhu H.W., Zhang C., Bian F., Shan J.P., and Lu W.I. Therapeutic effect of Astragalus in patients with chronic glomerulonephritis. Acta Univ Medicinalis Secondae Shanghai 22 (2002) 245-248
10. Cavallo T. Membranous nephropathy. Insights from Heymann nephritis. Am J Pathol 144 (1994) 651-658
11. Quigg R.J., Holers V.M., Morgan B.P., and Sneed III A.E. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J Immunol 154 (1995) 3437-3443
12. Nangaku M., Quigg R.J., Shankland S.J., Okada N., Johnson R.J., and Couser W.G. Overexpression of Crry protects mesangial cells from complement-mediated injury. J Am Soc Nephrol 8 (1997) 223-233
13. Cai Q., Li X., and Wang H. Astragali and Angelica protect the kidney against ischemia and reperfusion injury and accelerate recovery. Chin Med J (Engl) 114 (2001) 119-123
14. Thurman J.M., Ljubanovic D., Royer P.A., et al. Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest 116 (2006) 357-368
15. Thomas T.C., Rollins S.A., Rother R.P., et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol 33 (1996) 1389-1401